APA (7th ed.) Citation

X, L., J, H., X, S., Z, B., & J, L. (2023). Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: A systematic review and meta-analysis of randomized controlled trials. Archives of osteoporosis, 18(1), 37. https://doi.org/10.1007/s11657-023-01227-9

Chicago Style (17th ed.) Citation

X, Li, Han J, Shi X, Bi Z, and Liu J. "Zoledronic Acid and Denosumab for Periprosthetic Bone Mineral Density Loss After Joint Arthroplasty: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Archives of Osteoporosis 18, no. 1 (2023): 37. https://doi.org/10.1007/s11657-023-01227-9.

MLA (9th ed.) Citation

X, Li, et al. "Zoledronic Acid and Denosumab for Periprosthetic Bone Mineral Density Loss After Joint Arthroplasty: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Archives of Osteoporosis, vol. 18, no. 1, 2023, p. 37, https://doi.org/10.1007/s11657-023-01227-9.